nitrendipine has been researched along with amlodipine in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.76) | 18.7374 |
| 1990's | 15 (35.71) | 18.2507 |
| 2000's | 18 (42.86) | 29.6817 |
| 2010's | 7 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Beaumont, K; Smith, DA; van De Waterbeemd, H; Walker, DK | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Einzinger, U; Hoda, JC; Huber, IG; Koschak, A; Obermair, GJ; Sartori, SB; Sinnegger-Brauns, MJ; Striessnig, J; Wild, C | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Reimão, JQ; Scotti, MT; Tempone, AG | 1 |
| Sun, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Burburan, PJ; Matubia, VN; Parkin, DW; Ramcharan, SS; Rosario, I; Shea, TA; Stockman, BJ | 1 |
| Mason, RP; Moisey, DM; Shajenko, L | 1 |
| Borges, ET; Christeler, P; Guillaume-Gentil, M; Hollenstein, U; Mannhart, M; Waeber, B | 1 |
| Gambini, F; Gaviraghi, G; Micheli, D; Quartaroli, M; Tarter, G; Trist, DG | 1 |
| Block, LH; Emmons, LR; Erne, P; Matthys, H; Perruchoud, A; Roth, M | 1 |
| Beressem, P; Englert, R; Kramar, M; Stafunsky, M; von Manteuffel, E | 1 |
| Burges, RA; Carter, AJ; Gardiner, DG | 1 |
| Burges, RA; Carter, AJ; Dodd, MG; Gardiner, DG; Sutton, MR | 1 |
| Aguilera, MT; Coca, A; De la Sierra, A; Lluch, MM; Picado, MJ; Sánchez, M; Urbano-Márquez, A | 1 |
| Humphrey, MJ; Smith, DA; Walker, DK | 1 |
| Bachetti, T; Carboni, L; Ferri, S; Ratti, E; Spampinato, S; Van Amsterdam, FT | 1 |
| Feraco, E; Grandinetti, O | 1 |
| Gilar, M; Tesarová, E; Uhrová, M | 1 |
| Gong, L; Guo, J; Liu, Y; Wang, X; Yang, P; Ye, X; Zhang, G | 1 |
| Ishimitsu, T; Kawano, Y; Matsuoka, H; Minami, J; Numabe, A; Takishita, S | 1 |
| Dhein, S; Salameh, A | 1 |
| Ellsworth, A; Fink, KS | 1 |
| Chen, X; Gu, J; Guo, J; Li, X; Zhong, D | 1 |
| Chahwala, S; Hintze, TH; Loke, KE; Mital, S; Zhang, XP | 1 |
| Coratelli, P; Fassianos, E; Morrone, LF; Passavanti, G; Ramunni, A; Saracino, A | 1 |
| Jiang, YY; Miao, CY; Shen, FM; Su, DF; Xie, HH; Xu, LP | 1 |
| Basile, J | 1 |
| de la Figuera-von Wichman, M; de la Sierra-Iserte, A; Delgadillo-Duarte, J; Luque-Otero, M; Marín-Iranzo, R; Oliván-Martínez, J; Pontes-García, C; Redón-Mas, J; Roca-Cusachs, A | 1 |
| Beressem, P; Englert, R; Kramar, M; Stafunsky, S; von Manteuffel, E | 1 |
| Strauss, MH; Verma, S | 1 |
| Li, J; Li, QX; Liu, LL; Shao, L; Xia, L | 1 |
| Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
| Ao, Y; Li, J; Li, QX; Song, RJ; Tie, CR; Xie, XF | 1 |
| Beydemir, S; Söyüt, H; Türkeş, C | 1 |
2 review(s) available for nitrendipine and amlodipine
| Article | Year |
|---|---|
Property-based design: optimization of drug absorption and pharmacokinetics.
Topics: Animals; Biological Transport; Blood Proteins; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane; Drug Design; Eye; Humans; Intestinal Absorption; Models, Biological; Models, Molecular; Nasal Mucosa; Pharmaceutical Preparations; Pharmacokinetics; Prodrugs; Skin Absorption | 2001 |
The role of existing and newer calcium channel blockers in the treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Nifedipine; Nitrendipine; Treatment Outcome; Verapamil | 2004 |
10 trial(s) available for nitrendipine and amlodipine
| Article | Year |
|---|---|
Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Nitrendipine | 1992 |
Amlodipine compared to nitrendipine for the treatment of mild-to-moderate hypertension.
Topics: Amlodipine; Calcium Channel Blockers; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitrendipine; Vasodilation | 1991 |
Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension.
Topics: Adult; Aged; Amlodipine; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine | 1993 |
Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients.
Topics: Aged; Aging; Ambulatory Care; Amlodipine; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Male; Nitrendipine | 1993 |
Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Single-Blind Method | 1998 |
Amlodipine, a long-acting calcium channel blocker, attenuates morning blood pressure rise in hypertensive patients.
Topics: Amlodipine; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Cross-Over Studies; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine | 1999 |
[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg].
Topics: Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine | 2005 |
An open, parallel, comparative evaluation of amlodipine and nitrendipine in the monotherapeutic treatment of mild and moderate essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Female; Humans; Hypertension; Male; Nitrendipine; Severity of Illness Index | 1991 |
MOSES raises questions.
Topics: Acrylates; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Data Interpretation, Statistical; Humans; Imidazoles; Ischemic Attack, Transient; Nitrendipine; Research Design; Risk Factors; Stroke; Thiophenes | 2006 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
30 other study(ies) available for nitrendipine and amlodipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms.
Topics: Amino Acid Motifs; Animals; Brain; Calcium Channels, L-Type; Dihydropyridines; Female; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Isoforms | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cricetinae; Dihydropyridines; Erythrocytes; Leishmania; Macaca mulatta; Mice; Parasitic Sensitivity Tests; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Molecular Structure; N-Glycosyl Hydrolases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Trichomonas vaginalis | 2014 |
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
Topics: Amlodipine; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Nifedipine; Nitrendipine; Stroke Volume; Vascular Resistance; Verapamil | 1991 |
Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor.
Topics: Amlodipine; Calcium Channel Blockers; Cell Division; Cell Line; Cell Membrane; DNA Replication; Fibroblasts; Gene Expression; Genes; Humans; Hydroxymethylglutaryl CoA Reductases; Kinetics; Nifedipine; Nitrendipine; Platelet-Derived Growth Factor; Receptors, LDL; RNA, Messenger; Skin; Transcription, Genetic; Verapamil | 1991 |
Natriuretic activity of amlodipine, diltiazem, and nitrendipine in saline-loaded anesthetized dogs.
Topics: Amlodipine; Anesthesia; Animals; Calcium Channel Blockers; Diltiazem; Dogs; Female; Hemodynamics; Natriuresis; Nifedipine; Nitrendipine; Sodium; Time Factors | 1988 |
The hemodynamic properties of amlodipine in anesthetised and conscious dogs: comparison with nitrendipine and influence of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Amlodipine; Anesthesia; Animals; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Male; Nifedipine; Nitrendipine; Propranolol; Time Factors; Vascular Resistance | 1989 |
Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine.
Topics: Amlodipine; Animals; Drug Stability; Half-Life; Liver; Male; Metabolic Clearance Rate; Nitrendipine; Oxidation-Reduction; Protein Binding; Rats; Rats, Wistar; Tissue Distribution | 1994 |
Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cytosol; Dihydropyridines; Female; Fura-2; Muscle, Smooth, Vascular; Nifedipine; Nitrendipine; Potassium Chloride; Pregnancy; Rats; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1993 |
Enantiomer separation of dihydropyridine calcium antagonists with cyclodextrins as chiral selectors: structural correlation.
Topics: Amlodipine; Buffers; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclodextrins; Dihydropyridines; Electrolytes; Electrophoresis, Capillary; Isradipine; Microspheres; Molecular Conformation; Nimodipine; Nisoldipine; Nitrendipine; Sodium Dodecyl Sulfate; Solvents; Stereoisomerism; Surface-Active Agents | 1996 |
Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Microcirculation; Nitrendipine; Nitric Oxide; Swine | 1999 |
Antihypertensive treatment and CHD in the elderly.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Double-Blind Method; Felodipine; Fosinopril; Humans; Hypertension; Myocardial Infarction; Nisoldipine; Nitrendipine; Randomized Controlled Trials as Topic | 1999 |
Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses.
Topics: Amlodipine; Chromatography, Liquid; Humans; Mass Spectrometry; Nitrendipine; Propafenone; Roxithromycin; Sensitivity and Specificity | 2001 |
Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine.
Topics: Amlodipine; Animals; Bradykinin; Calcium Channel Blockers; Calcium Channels, L-Type; Coronary Vessels; Dogs; In Vitro Techniques; Male; Microcirculation; Myocardium; Nitrendipine; Nitric Oxide; Nitrites; Oxygen Consumption; Stereoisomerism; Structure-Activity Relationship | 2002 |
[Innovation, step innovation, Me too. Are calcium antagonists interchangeable?].
Topics: Aged; Amlodipine; Calcium Channel Blockers; Delayed-Action Preparations; Heart Failure; Humans; Hypertension; Nitrendipine; Risk Factors; Time Factors; Vasodilator Agents | 2001 |
Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
Topics: Adult; Amlodipine; Enalapril; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrendipine; Renal Circulation; Vascular Resistance | 2003 |
Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Evaluation, Preclinical; Drug Synergism; Female; Hypertension; Male; Nitrendipine; Rats; Rats, Inbred SHR | 2004 |
Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats.
Topics: Amlodipine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Calcium Channel Blockers; Creatinine; Doxorubicin; Glutathione; Glutathione Transferase; Kidney; Kidney Diseases; Male; Malondialdehyde; Nifedipine; Nitrendipine; Nitric Oxide; Nitric Oxide Synthase; Proteinuria; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2007 |
Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats.
Topics: Acetylglucosaminidase; Amlodipine; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Calcium Channel Blockers; Creatine; Gene Expression Regulation; Gentamicins; Glutathione; Glutathione Transferase; Kidney Tubules; Male; Malondialdehyde; Nifedipine; Nitrendipine; Nitric Oxide; Nitric Oxide Synthase; Proteinuria; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2009 |
Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress.
Topics: Amlodipine; Aryldialkylphosphatase; Calcium Channel Blockers; Humans; Isradipine; Nifedipine; Nitrendipine; Oxidative Stress | 2014 |